• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM46 通过修饰 PHLPP2 的泛素化来激活 AKT/HK2 信号通路,从而促进肺癌细胞的糖酵解和化疗耐药性。

TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells.

机构信息

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.

出版信息

Cell Death Dis. 2022 Mar 30;13(3):285. doi: 10.1038/s41419-022-04727-7.

DOI:10.1038/s41419-022-04727-7
PMID:35354796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8967906/
Abstract

The incidence of lung cancer is increasing worldwide. Although great progress in lung cancer treatment has been made, the clinical outcome is still unsatisfactory. Tripartite motif (TRIM)-containing proteins has been shown to be closely related to tumor progression. However, the function of TRIM46 in lung cancer is largely unknown. Here, TRIM46 amplification was found in lung adenocarcinoma (LUAD) tissues and TRIM46 amplification was significantly associated with a poor survival rate. Overexpression of wild type TRIM46 increased the proliferation of LUAD cells and glycolysis, promoted xenografts growth, and enhanced cisplatin (DDP) resistance of LUAD cells via increased ubiquitination of pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2) and upregulation of p-AKT. In contrast, overexpression of RING-mutant TRIM46 did not show any effects, suggesting the function of TRIM46 was dependent on the E3 ligase activity. Furthermore, we found that TRIM46 promoted LUAD cell proliferation and DDP resistance by enhancing glycolysis. PHLPP2 overexpression reversed the effects of TRIM46 overexpression. Amplification of TRIM46 also promoted LUAD growth and enhanced its DDP resistance in a patient-derived xenograft (PDX) model. In conclusion, our data highlight the importance of TRIM46/PHLPP2/AKT signaling in lung cancer and provide new insights into therapeutic strategies for lung cancer.

摘要

肺癌的发病率在全球范围内呈上升趋势。尽管在肺癌治疗方面取得了巨大进展,但临床疗效仍不尽如人意。三结构域蛋白(TRIM)家族蛋白与肿瘤的发生发展密切相关。然而,TRIM46 在肺癌中的作用尚不清楚。本研究发现 TRIM46 在肺腺癌(LUAD)组织中扩增,并且 TRIM46 扩增与生存率降低显著相关。野生型 TRIM46 的过表达可增加 LUAD 细胞的增殖和糖酵解,促进异种移植瘤的生长,并通过增加 PH 结构域富含亮氨酸重复蛋白磷酸酶 2(PHLPP2)的泛素化和 AKT 的磷酸化来增强 LUAD 细胞对顺铂(DDP)的耐药性。相比之下,过表达 RING 突变型 TRIM46 则没有显示出任何效果,这表明 TRIM46 的功能依赖于 E3 连接酶的活性。此外,我们发现 TRIM46 通过增强糖酵解促进 LUAD 细胞增殖和 DDP 耐药性。PHLPP2 的过表达逆转了 TRIM46 过表达的作用。TRIM46 的扩增也促进了 PDX 模型中 LUAD 的生长并增强了其对 DDP 的耐药性。综上所述,我们的数据强调了 TRIM46/PHLPP2/AKT 信号通路在肺癌中的重要性,并为肺癌的治疗策略提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/17ad8f3d5295/41419_2022_4727_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/997ef1ef362d/41419_2022_4727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/78064ebc0e56/41419_2022_4727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/ba179925192e/41419_2022_4727_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/ff0ac660d0c4/41419_2022_4727_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/d943d2644a25/41419_2022_4727_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/f7c0acdd4c14/41419_2022_4727_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/3e8bb007a946/41419_2022_4727_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/17ad8f3d5295/41419_2022_4727_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/997ef1ef362d/41419_2022_4727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/78064ebc0e56/41419_2022_4727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/ba179925192e/41419_2022_4727_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/ff0ac660d0c4/41419_2022_4727_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/d943d2644a25/41419_2022_4727_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/f7c0acdd4c14/41419_2022_4727_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/3e8bb007a946/41419_2022_4727_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c52/8967906/17ad8f3d5295/41419_2022_4727_Fig8_HTML.jpg

相似文献

1
TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells.TRIM46 通过修饰 PHLPP2 的泛素化来激活 AKT/HK2 信号通路,从而促进肺癌细胞的糖酵解和化疗耐药性。
Cell Death Dis. 2022 Mar 30;13(3):285. doi: 10.1038/s41419-022-04727-7.
2
PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.PRDM14 介导耐药 A549/cisplatin 细胞及其祖细胞 A549 人肺腺癌细胞的化疗敏感性和糖酵解。
Mol Med Rep. 2021 Feb;23(2). doi: 10.3892/mmr.2020.11788. Epub 2020 Dec 23.
3
TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.TFAP2A 通过上调 SKA3 促进肺腺癌细胞的糖酵解并降低顺铂敏感性。
Pharmacology. 2024;109(4):202-215. doi: 10.1159/000536557. Epub 2024 Apr 22.
4
UBE4B promotes the development of lung adenocarcinoma by enhancing proliferation, migration and glycolysis via PP2A/AKT signaling.UBE4B 通过激活 PP2A/AKT 信号通路促进肺腺癌的增殖、迁移和糖酵解。
Pathol Res Pract. 2022 Apr;232:153762. doi: 10.1016/j.prp.2022.153762. Epub 2022 Jan 7.
5
APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.APE1 通过一种依赖氧化还原的机制激活 Akt 信号通路从而刺激肺腺癌对 EGFR-TKI 的耐药性。
Cell Death Dis. 2018 Oct 31;9(11):1111. doi: 10.1038/s41419-018-1162-0.
6
Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.三结构域包含蛋白 46 通过泛素化 PPAR 激活 NF-B 信号通路促进骨肉瘤细胞的存活和抑制细胞凋亡。
Oncol Res. 2020 Sep 1;28(4):409-421. doi: 10.3727/096504020X15868639303417. Epub 2020 Apr 15.
7
XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.XPC 抑制通过 Akt/mTOR 信号通路拯救 A549/DDP 肺腺癌细胞中的顺铂耐药性。
Oncol Rep. 2019 Mar;41(3):1875-1882. doi: 10.3892/or.2019.6959. Epub 2019 Jan 9.
8
Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway.参麦注射液通过 AKT-mTOR-c-Myc 信号通路抑制顺铂耐药 A549/DDP 细胞的糖酵解并增强顺铂的细胞毒性。
Biomed Res Int. 2020 Jun 20;2020:9243681. doi: 10.1155/2020/9243681. eCollection 2020.
9
Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma.TRIM23 表达升高预示肺腺癌对顺铂耐药。
Cancer Sci. 2020 Feb;111(2):637-646. doi: 10.1111/cas.14226. Epub 2020 Jan 17.
10
miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.miR-205 靶向 PTEN 和 PHLPP2 以增强 AKT 信号通路并驱动非小细胞肺癌的恶性表型。
Cancer Res. 2013 Sep 1;73(17):5402-15. doi: 10.1158/0008-5472.CAN-13-0297. Epub 2013 Jul 15.

引用本文的文献

1
AFF4 promotes tumor progression and cisplatin resistance by modulating the PTEN/PI3K/AKT/mTOR axis to accelerate glycolysis in lung adenocarcinoma.AFF4通过调节PTEN/PI3K/AKT/mTOR轴促进肺腺癌的糖酵解,从而促进肿瘤进展和顺铂耐药。
Cell Biosci. 2025 Aug 11;15(1):116. doi: 10.1186/s13578-025-01455-1.
2
A pilot multi-omics study reveals genetic mechanisms regulating milk component traits in dairy cattle.一项先导性多组学研究揭示了调控奶牛乳成分性状的遗传机制。
Commun Biol. 2025 Aug 4;8(1):1150. doi: 10.1038/s42003-025-08615-6.
3
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK.

本文引用的文献

1
A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis.基于基因的肺腺癌生存评分:多个转录组数据集分析。
BMC Cancer. 2020 Oct 31;20(1):1046. doi: 10.1186/s12885-020-07473-1.
2
The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival.磷酸酶PHLPP2在胰腺β细胞存活调节中起关键作用。
Int J Endocrinol. 2020 Jan 3;2020:1027386. doi: 10.1155/2020/1027386. eCollection 2020.
3
Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.
TRIM65通过对AMPK进行泛素化和降解来调节葡萄糖代谢重编程,从而促进胶质瘤细胞增殖。
NPJ Precis Oncol. 2025 Jun 5;9(1):163. doi: 10.1038/s41698-025-00964-z.
4
The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products.己糖激酶2(HK2)在肿瘤发生发展中的作用:天然产物靶向治疗的潜力
Int J Med Sci. 2025 Jan 21;22(4):790-805. doi: 10.7150/ijms.105553. eCollection 2025.
5
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities.肺癌中PI3K信号通路的靶向治疗:进展、挑战与治疗机遇
J Transl Med. 2025 Feb 14;23(1):184. doi: 10.1186/s12967-025-06144-8.
6
Enhanced Expression of TRIM46 in Ovarian Cancer Cells Induced by Tumor-Associated Macrophages Promotes Invasion via the Wnt/β-Catenin Pathway.肿瘤相关巨噬细胞诱导的卵巢癌细胞中TRIM46表达增强通过Wnt/β-连环蛋白途径促进侵袭。
Cells. 2025 Feb 2;14(3):214. doi: 10.3390/cells14030214.
7
Comprehensive analysis of ferroptosis-related genes indicates that TRIM46 is a novel biomarker and promotes the progression of ovarian cancer via modulating ferroptosis and Wnt signaling pathway.对铁死亡相关基因的综合分析表明,TRIM46是一种新型生物标志物,通过调节铁死亡和Wnt信号通路促进卵巢癌的进展。
Am J Cancer Res. 2024 Oct 15;14(10):4686-4707. doi: 10.62347/ONUY8904. eCollection 2024.
8
Multifaceted role of in health and disease.[此处原文不完整,缺少具体所指内容]在健康与疾病中的多方面作用。
MedComm (2020). 2024 Nov 11;5(11):e790. doi: 10.1002/mco2.790. eCollection 2024 Nov.
9
Nimodipine Used with Vincristine: Protects Schwann Cells and Neuronal Cells from Vincristine-Induced Cell Death but Increases Tumor Cell Susceptibility.尼莫地平联合长春新碱:保护许旺细胞和神经元细胞免受长春新碱诱导的细胞死亡,但增加肿瘤细胞的敏感性。
Int J Mol Sci. 2024 Sep 27;25(19):10389. doi: 10.3390/ijms251910389.
10
TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth.TRIM33 通过调节 P53 K48 连接的泛素化促进糖酵解,从而促进食管鳞状细胞癌的生长。
Cell Death Dis. 2024 Oct 10;15(10):740. doi: 10.1038/s41419-024-07137-z.
三结构域包含蛋白 46 通过泛素化 PPAR 激活 NF-B 信号通路促进骨肉瘤细胞的存活和抑制细胞凋亡。
Oncol Res. 2020 Sep 1;28(4):409-421. doi: 10.3727/096504020X15868639303417. Epub 2020 Apr 15.
4
mA-dependent glycolysis enhances colorectal cancer progression.mA 依赖性糖酵解增强结直肠癌进展。
Mol Cancer. 2020 Apr 3;19(1):72. doi: 10.1186/s12943-020-01190-w.
5
The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism.肺癌的代谢格局:葡萄糖代谢紊乱中的新见解
Front Oncol. 2019 Nov 15;9:1215. doi: 10.3389/fonc.2019.01215. eCollection 2019.
6
Copy number variation is highly correlated with differential gene expression: a pan-cancer study.拷贝数变异与差异基因表达高度相关:泛癌症研究。
BMC Med Genet. 2019 Nov 9;20(1):175. doi: 10.1186/s12881-019-0909-5.
7
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.致癌信号与癌症代谢交界处的 PI3K-AKT 网络。
Nat Rev Cancer. 2020 Feb;20(2):74-88. doi: 10.1038/s41568-019-0216-7. Epub 2019 Nov 4.
8
Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.抑制 PI3K/Akt/mTOR 信号通路通过逆转上皮-间充质转化和降低癌症干细胞标志物表达来减轻卵巢癌的化疗耐药性。
BMC Cancer. 2019 Jun 24;19(1):618. doi: 10.1186/s12885-019-5824-9.
9
Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses.含三联基序蛋白15在非小细胞肺癌中的过表达与患者预后不良相关。
J Cancer. 2019 Jan 29;10(4):843-852. doi: 10.7150/jca.27856. eCollection 2019.
10
High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer.肝硬化中糖酵解基因的高表达与患肝癌风险相关。
Front Cell Dev Biol. 2018 Oct 31;6:138. doi: 10.3389/fcell.2018.00138. eCollection 2018.